nivolumab,cabozantinib
bms,exelixis
['nivo', 'renal,(-adrenal)', 'nivolumab', 'cabozantinib']
nivolumab/cabozantinib associated with greater proportion of deep objective responses for advanced renal cell carcinoma #asco22
Chief MedOnc @SylvesterCancer. Helping improve Cancer Control in LMICs. Editor-in-Chief @JCOGO_ASCO, Board Member @UICC - co-chair #ATOMcoalition